Glycogen Synthase Kinase-3β in Ischemic Neuronal Death

ISSN: 1875-5739 (Online)
ISSN: 1567-2026 (Print)

Volume 11, 4 Issues, 2014

Download PDF Flyer

Current Neurovascular Research

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 65th of 193 in Clinical Neurology
  • 130th of 252 in Neurosciences

Submit Abstracts Online Submit Manuscripts Online

Prof. Kenneth Maiese
Neurology and Neurosciences UMDNJ
205 South Orange Avenue, F1220
Newark, NJ 07101

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.844
5 - Year: 2.932

Glycogen Synthase Kinase-3β in Ischemic Neuronal Death

Author(s): H Pradeep, Asha Densi and G. K Rajanikant

Affiliation: Centre for Bioinformatics National Institute of Technology Calicut Calicut - 673601, India


Glycogen synthase kinase 3β (GSK-3β) is implicated in diverse cellular processess such as cell signaling and survival. Accumulating lines of evidence indicate that increased GSK-3β activity contributes to neuronal death and to the pathogenesis of ischemic stroke. Considering predominant roles of GSK-3β in neuronal apoptosis, manipulation of this protein kinase is a promising strategy for ischemic neuroprotection. In this review, we survey and synthesize the current knowledge about the role of GSK-3β in neuroprotection following the ischemic stroke

Keywords: Apoptosis, brain, GSK-3β, hypoxia, ischemic stroke, neuronal death

Purchase Online Rights and Permissions

Article Details

Volume: 11
First Page: 1
Last Page: 8
Page Count: 8
DOI: 10.2174/1567202611666140520151002

Related Journals

Webmaster Contact: Copyright © 2014 Bentham Science